Supplementary Data: STK1p as a prognostic biomarker for overall survival in non-small cell lung carcinoma, based on real-world-data..docx

<b>Supplementary Material</b>. STK1p as a prognostic biomarker for overall
survival in non-small cell lung carcinoma, based on real-world-data.

Although the patients of early stages (I-IIIA)
showed a good prognosis with high OS rates (Table 1, figure 1B), it was noted
that 3 patients of stage IIA-IIB died within 14-20 months after end of the
treatment. We observed that the STK1p values after 2-cycle
individual-chemotherapy did not returned to normal values (&lt;0.6 pM),
characterized as NR (no response, SD) by CT examination. The main reason for
the death might be development of metastasis. Here we report a case analysis of
these three patients to prove the significant correlations between STK1p values
and clinical data in this RWD study.